Your browser doesn't support javascript.
loading
[Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
Jiang, Ya-Jun; Zhang, Chun-Fang; Wang, Hong-Xia; Zhao, Lan; Zhang, Fei-Fei; Han, Xiu-Hua.
Afiliación
  • Jiang YJ; Department of Hematology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
  • Zhang CF; Department of Pathology, The First People's Hospital of Lianyungang, Lianyungang 222002, Jiangsu Province, China.
  • Wang HX; Department of Pathology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.E-mail: jiangyajun-2001@163.com.
  • Zhao L; Department of Hematology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
  • Zhang FF; Department of Hematology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
  • Han XH; Department of Hematology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 32(1): 27-32, 2024 Feb.
Article en Zh | MEDLINE | ID: mdl-38387895
ABSTRACT

OBJECTIVE:

To investigate the clinical significance of genetic and molecular changes in primary myeloid sarcoma (MS).

METHODS:

Fourteen patients with primary MS were selected in Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, The First People's Hospital of Lianyungang from September 2010 to December 2021. AML1-ETO fusion, PML-RARα fusion and CBFß breakage were detected by fluorescence in situ hybridization (FISH), and the mutations of NPM1, CEBPA, FLT3, RUNX1, ASXL1, KIT and TP53 genes were detected by new generation sequencing (NGS).

RESULTS:

Among 14 patients, the MS occurred in bone, breast, epididymis, lung, chest wall, cervix, small intestine, ovary, lymph nodes and central nervous system. The tumor cells expressed MPO (13 cases), CD34 (7 cases), CD43 (8 cases), CD68 (7 cases), CD99 (8 cases) and CD117 (6 cases). Cytogenetic abnormalities were observed in 4 cases, including 3 cases of AML1-ETO fusion and 1 case of CBFß breakage, while no PML-RARα fusion was detected. There were no significant differences in overall survival (OS) and leukemia-free survival (LFS) between patients with and without AML1-ETO fusion/CBFß breakage (both P >0.05). Among the 14 patients, the number of NPM1, CEBPA, FLT3-ITD, RUNX1, ASXL1, KIT and TP53 gene mutations was 5, 3, 5, 3, 2, 2, 1, respectively, of which 7 cases had at least one mutation in FLT3-ITD, RUNX1, ASXL1 and TP53 gene. The OS and LFS of patients with FLT3-ITD, RUNX1, ASXL1 or TP53 mutation were shorter than those without mutations (both P <0.01).

CONCLUSION:

The genetic and molecular abnormalities of primary MS can be detected by FISH and NGS techniques. FLT3-ITD, RUNX1, ASXL1 or TP53 mutation indicates a worse prognosis, but further clinical studies are needed to confirm it.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma Mieloide / Subunidad alfa 2 del Factor de Unión al Sitio Principal Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma Mieloide / Subunidad alfa 2 del Factor de Unión al Sitio Principal Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China